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Abstract— Within the life sciences switching mechanisms are
pervasive at all levels, from molecules to cells and tissues. Their
operation can be a key determinant of health or disease. Whilst
the existence and importance of switches is widely acknowl-
edged within the biological literature, many life scientists do
not deal explicitly with the switching behaviour. Frequently,
steady-state behaviour before and after switching is the primary
focus. Here methods for analysis of switched systems from
control engineering are applied to the modelling and analysis
of a riboswitch. The model has been developed by studying the
dynamics of the vitamin B12 riboswitch. The simulation results
have been validated using in vivo experiments by checking the
bacterial growth when using Escherichia coli and Salmonella
enterica where the action of the vitamin B12 riboswitch is
known to be a determinant of system behaviour. The paper
first describes a simple model for the B12-riboswitch regulatory
network in E. coli and applies the same analysis when changing
the strain to S. enterica. Validation of the simulation results has
been undertaken by linking the dynamics of the riboswitch to
bacterial growth.
I. INTRODUCTION
Vitamin B12, the cyano-derivative of cobalamin, is a
water-soluble vitamin whose biological forms play key roles
in metabolism that affect the normal functioning of the
brain and nervous system in humans. Herein, we use the
term B12 generically to refer to cobalamin. B12 is unique
among the vitamins in that it is made exclusively by only
certain prokaryotes and there is significant interest in how
B12 production is controlled within microbial communities
and how the nutrient makes its way through the food chain
into animals. For humans B12 deficiency is most often
associated with an autoimmune disorder that prevents the
body from absorbing the nutrient but people on a strictly
vegetarian diet are also prone to deficiency as plants neither
make nor require B12. In fact, dietary B12 deficiency is a
severe problem in many developing countries including the
Indian subcontinent, Mexico, central and South America and
selected areas of Africa [1]. Moreover, B12 deficiency is
also a common problem for the 115000 sufferers of Crohn’s
disease in the UK and millions more worldwide as the
inflammation caused by the condition can affect the end of
the ileum, which is the main area where B12 is absorbed [2].
To understand the control of B12 availability it is important
to study the gene regulatory network (GRN), which is a
collection of molecular regulators that interact with each
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other and with other substances in the cell to govern the
gene expression [3].
Riboswitches are naturally occurring RNA-based regulatory
components that essentially function by first sensing specific
metabolites such as cofactors, amino acids and nucleotides
and then regulating the expression level of proteins in the
corresponding metabolic pathways [4]. The switches undergo
a conformational change in response to a small-molecule lig-
and whereby increasing ligand concentrations either increase
or decrease gene expression. The steadily increasing number
of examples of such natural RNA regulators that control
gene expression through diverse mechanisms in different
organisms has fostered growing interest in using RNA to
build synthetic controllers. Both naturally occurring and syn-
thetic riboswitches are seen to be highly tunable components
capable of regulating gene expression.
Some work to model riboswitch function has taken place
and useful guidelines have been developed for tuning, but
this work has been performed under steady-state operating
conditions. The literature on the tuning of riboswitches
also focusses primarily on the riboswitch as an individual
element rather than as a component within a wider biological
pathway [5]. The mathematical model which is used in this
paper is based on the riboswitch regulatory pathway [3].
This riboswitch is capable, in principle, of regulating BtuB,
which is an outer membrane porin that mediates high affinity
binding and TonB- dependent active transport of vitamin B12
across the outer membrane. Regulation at the transcriptional
level occurs when a B12 molecule binds the riboswitch
aptamer domain and causes the formation of a terminator
structure in the riboswitch expression platform. After esti-
mating the parameters of the model, the system has been
validated by creating an equation for the bacterial growth
and it is proved experimentally that the model reproduces the
system behaviour and captures the system dynamics within
suitable bounds. For validation purposes, the growth levels
in vitamin B12-dependent bacteria were determined when
grown in environments containing different concentrations
of vitamin B12. E. coli and S. enterica strains were used in
the experiments and the growth levels were measured using
optical density data recorded on triplicates at 600 nm. The
verification process was performed by comparing simulation
and experimental results. In addition, the assessment of the
saturation effect when the concentration is high or low has
been studied. The organisation of the paper is as follows:
first, a preliminary analysis for the model of vitamin B12 is
conducted. Second, the model validation is undertaken and
finally, a comparison between the analytical analysis and the
experimental results is made.
II. ANALYSIS OF A SIMPLE MODEL OF THE
VITAMIN B12 RIBOSWITCH
The mathematical model which is used in this paper is
based on the riboswitch regulatory pathway. Gene expression
can be regulated at several levels in a cell. Differential gene
transcription regulates which genes are allowed to be tran-
scribed into RNA while selective nuclear RNA processing
regulates which transcribed RNA can enter the cytoplasm
and become messenger RNA. Genes can be regulated any
time before, after or during the processes of translation and
transcription. E. coli is incapable of synthesizing vitamin
B12. Instead, these bacteria actively transport the vitamin
from the environment. BtuB, which is encoded by gene btuB,
is an important component of the vitamin B12 transporter.
Gene btuB is negatively regulated by vitamin B12 via a
riboswitch. To develop a mathematical model for the B12-
riboswitch regulatory network in E. coli, Santillan et al.
(2005) [3] identified three normalised model variables m, e
and p which respectively represent the concentration of btuB
mRNA , the concentration of BtuB and the concentration of
vitamin B12. The model itself is described by:
m˙ = γ [φ(p)−m] (1)
e˙ = ξ [mθ(p)− e] (2)
p˙ = δ [(Pext) e− p] (3)
The biological meaning of the parameters in (1) - (3) are
shown in Table I. The functions φ(p) and θ(p) denote the
B12-governed regulation at the transcriptional and transla-
tional levels respectively. These functions are shown to be
given by the following Michaelis-Menten equations:
φ(p) =
Kφ
Kφ + p
θ(p) =
Kθ
Kθ + p
Santillan et al. [3] presents simulation results that have
TABLE I: Pre-determined parameters in the mathematical
model (1) - (3)
Symbol Biological meaning Original / New
Experimental Value
γ The mRNA degradation rate 7.1 × 10−2
ξ The btuB degradation rate 0.8 × 10−2
δ The B12 degradation rate 0.8 × 10−2
(Pext) Represent the type of the strain 25
Kφ
The dissociation constant
at the transcriptional level 1/4 / 2.25 × 10
−6
Kθ
The dissociation constant
at the translation level 1/4 / 2.25 × 10
−6
been undertaken for only 600 minutes, and the steady state
value for the concentration of the vitamin B12 is 1. When
the simulation is run for a longer time (1500 minutes), the
concentration of vitamin B12 increases again after 900 min-
utes as shown in Fig. 1. This is an unexpected response and
does not match the expected experimental results because
the system should switch off when the concentration goes to
zero. The controls Φ(P ) and Θ(P ) in the Michaelis-Menten
(a) Concentration of vitamin B12
(b) Controller
Fig. 1: The simulation results for the concentration of vitamin
B12 and the controller in the original paper [3]
equations depend on the value of the concentration of vitamin
B12, which is the third variable in the mathematical model
(1) - (3) and thus the control system response is as shown
in Fig. 1. As this does not match the expected experimental
results, the parameters of the mathematical model (1) - (3)
need to be modified. In the original paper [3], the dissociation
constants at the transcription (Kφ) and translation (Kθ) levels
are considered to be 1/4. Using this value, the steady-state
value for the concentration will increase after 900 minutes.
Based on the literature [8], [9] the dissociation constant
for the reaction has a smaller magnitude. By changing the
dissociation constant to 2.25 × 10−6, the concentration
output is correct and matches the results expected from
experiments. The new parameter values are shown in Table I.
The simulations using the modified parameters were carried
out by solving (1) - (3) with MATLAB as shown in Fig. 2.
Initial conditions of the normalised concentration of btuB
mRNA, the concentration of BtuB and the concentration
of vitamin B12 were chosen as m(0) = 1, e(0) = 1 and
p(0) = 0. All the simulations shown in this study used the
same initial conditions. It is recognised from the simulation
results of model (1) - (3) that the concentration of btuB
mRNA has a rapid transient and thus it is assumed that
Fig. 2: Concentration of Vitamin B12 following simulation
for 1500 minutes
this has reached steady-state in the subsequent analysis. The
system’s order is thus reduced to yield:
e˙ = ξ [φ(p) θ(p)− e] (4)
p˙ = δ [(Pext) e− p] (5)
using the steady-state value of m given by φ(p). There are
several parameters that affect the reduced order mathematical
model of the regulation equations for the B12 riboswitch
as shown in (4) - (5). These parameters are the BtuB
degradation rate, the B12 degradation rate and the value that
is used to show which strain has been used (). The effect
of varying these parameters on the concentration of vitamin
B12 and the bacterial growth rate will be considered.
III. MODEL VALIDATION
To validate the model, it is necessary to model the growth
curve from (4) - (5) and compare it with the growth curve
obtained from the experiments. The comparison will include
different levels of vitamin B12 concentration (50pM - 1nM).
The effect of the parameters will be described in detail. For
example, the relation between the concentration of vitamin
B12 and the growth will be considered. Bacteria have three
growth phases as shown in Fig 3.
Fig. 3: Bacterial growth curve
1) Lag phase: when cells are transferred to fresh media,
they require time to detect the environment, express
specific genes, and synthesize components necessary
for rapid growth. The cells are not dividing at this
time.
2) Exponential (log) phase: binary fission occurs at a
maximum rate, the cells are dividing as rapidly as
possible.
3) Stationary phase: at this point, growth has stopped
and there is no net increase or decrease in the number
of cells. Bacteria use new forms of metabolism to sur-
vive in some cases producing secondary metabolites.
A model incorporating the effect of varying concentration of
vitamin B12 with the OD600 bacterial growth output (which
denotes the absorbance, or optical density, of a sample
measured at a wavelength of 600 nm) is shown below:
OD600 =

ODLag phase, if t ≤ tl
[(
0.057× Pmax
ts − tl )× (t− tl)] +ODLag phase
if tl ≤ t ≤ ts]
ODts , if t ≥ ts
(6)
The parameters used in this equation with their biological
meanings and experimental values are listed in Table II.
TABLE II: Pre-determined parameters in the growth equation
(OD600)
Symbol Biological meaning Experimental Value
The absorbance at
ODLag phase OD600 when the growth 0.1
is at the lag phase
tl Time to reach the log phase 400
Time to reach the Varies depending
ts saturation phase on vitamin B12
concentration
The absorbance at Varies depending
ODts OD600 when the growth on vitamin B12
is at the saturation phase concentration
The initial number of bacteria, bacterial type and the exper-
imental environment depends on the particular experimental
conditions. Table II presents a set of parameters consistent
with the experiments performed. This choice may be justified
by considering Fig. 4. Pmax is defined to be the maximum
value of the concentration of vitamin B12 and ts is defined to
be the time at which the maximum is reached. These values
have been computed directly from the model (4) - (5) and can
also be identified from the experimental results. It is clear
that Pmax and ts vary with the change of Btub degradation
rate ξ. Figure 5 shows Pmax corresponding to different
values of ξ. Changing the bacterial strain will also change
Pmax and this is demonstrated both from simulation and
experimental results as shown in Fig. 6. Simulations were
carried out by solving (4) - (5) and applying the simulation
results in the growth equation. It is seen that by increasing
the concentration of vitamin B12, the absorbance at OD600
Fig. 4: Experimentally measured E.coli growth curves with
varying vitamin B12 concentration (50pM to 1nM)
(a) 0.8 × 10−2 (b) 1.8 × 10−2
Fig. 5: The concentration of Vitamin B12 when changing ξ
from 0.8 × 10−2 to 1.8 × 10−2
will increase and the time required to reach the steady-state
value will decrease. The time required to reach the stationary
phase and the absorbance at OD600 for both simulation and
experimental results for all concentrations is shown in Table
III and Table IV. Fig. 4 shows the experimentally measured
growth curve of E. coli with varying B12 concentration be-
tween 50pM and 1nM across three growth phases. In the lag
phase, there is no change between the curves even when the
concentration is changed. That is because the system requires
time to detect the environment and synthesize components
necessary for rapid growth while in the exponential phase. By
changing the concentration of vitamin B12, the growth curve
changes. From Fig. 4, it is seen that the OD600 during the
lag phase is 0.1 and ts is 400 minutes. These two values vary
from one plate reader to another as they are dependent on the
number of bacteria present when the experiment is initialised
and the atmospheric conditions in the laboratory, which may
change. The exponential phase starts from 400 minutes to
reach ts. The value of ts has a negative relation with the
concentration of vitamin B12, so when the concentration
of vitamin B12 increases, the value of ts decreases. In the
stationary phase, the bacterial growth stops and there is no
net increase or decrease in the number of cells. Varying the
concentration of vitamin B12 will change the steady state
value of absorbance. For example, when the concentration
of vitamin B12 is 50pM, the value of absorbance at OD600
(a) Growth curve for 75pM when  = 25
(b) Growth curve for 75pM when  = 21.5
Fig. 6: Comparison between the experimental and the simu-
lation results when changing the value of 
is 0.53 and when the concentration of vitamin B12 is 100pM,
the value of absorbance at OD600 is 0.61 as shown in Fig.
7.
IV. DISCUSSION
To validate the model, a comparison has been made
between the experimental results and the simulation results
as shown in Fig. 6. Table III shows a comparison between the
TABLE III: Comparison between the time required to reach
the stationary phase experimentally and the time required for
the concentration to reach zero mathematically.
Concentration of Time required to reach Time required to reach
Vitamin B12 the stationary phase the stationary phase
in Fig. 6, 7 (mins) in Fig. 6, 7 (mins)
Simulation Results Experimental Results
50 pM 1330 1497
75 pM 1170 1170
85 pM 1140 1135
100 pM 1090 1061
time required to reach the stationary phase in simulation and
experimentally while varying the concentration of vitamin
B12. It is clear that by increasing the concentration, growth
is faster and it reaches the stationary phase more rapidly.
In addition, by increasing the concentration the maximum
value of the simulated concentration will increase and thus
the absorbance at 600 nm will increase as shown in Table IV.
Growth reaches the stationary phase when the concentration
TABLE IV: Comparison between the absorbance at OD600
in the experiment and in the simulation.
Concentration of vitamin B12 Simulation Experiment
50 pM 0.503 0.532
75 pM 0.57 0.53
85 pM 0.61 0.57
100 pM 0.66 0.61
of vitamin B12 goes to zero. By increasing the concentration,
the time to reach the stationary phase decreases. Fig. 7 shows
a comparison between the experimental results and the simu-
lation results for the growth curve when the concentration of
vitamin B12 is 50pM and when it is 100pM. The simulation
results have a similar trend to the experimental observations
in terms of bacterial growth, peak values and steady-state
values. The value of  is related to the strain for each bacteria
(a) 50pM
(b) 100pM
Fig. 7: Comparison between the experimental and the mathe-
matical growth curve with different concentration of Vitamin
B12
that has been used. Here, E. coli and S. enterica are used
and they have different growth curves as shown in Fig. 6.
The experiments correspond to the wild-type E. coli and 375
mutant strain S. enterica [10]. The values of  employed in
these simulations are as follows:  = 25 (wild-type strain),  =
21.5 (375 mutant strain). The value of absorbance at OD600
Fig. 8: Comparison between the simulation and experimental
growth curve for E.coli with concentration of 25pM
increases when the value of  increases. From Fig. 6, the
absorbance at OD600 is 0.63 when  = 25 and it decreases
to 0.52 when  = 21.5.
After the model has been validated, an expected growth
curve when the concentration of vitamin B12 is 25pM
has been generated based only on the mathematical model.
Experimental results were then obtained to verify the predic-
tions. Fig. 8 shows the comparison between the simulated
and experimental growth curve for E. coli with a concen-
tration of 25pM. The model parameter tl in (6) is zero and
OD600 at the lag phase is 0.15. This setting is based on the
plate that has been used for the experiments where it should
be noted that results vary between plates.
It can be concluded that there is a positive relation between
the concentration of vitamin B12 and bacterial growth,
as when the concentration of vitamin B12 increases, the
growth curve increases. Moreover, when the concentration of
vitamin B12 increases to a certain level, it should be noted
that bacterial growth will saturate. Comparing simulation and
experimental results, it can be seen that the value of the
concentration when the growth saturates is 1 nM; increasing
the concentration of vitamin B12 by more than 1 nM, pro-
duces no change in the growth curve. Using the experimental
results shown in Fig. 9a which are the experimental growth
curve results for E. coli when the concentration of vitamin
B12 is between 1nM and 100 µM, the experimental results
agreed with the observed simulation results. In addition, this
shows that for all the concentrations (1nM - 100 µM ),
the bacterial growth curve is approximately the same. Fig.
9b shows the growth curve for E. coli when varying the
concentration of vitamin B12 between 1 pM and 10 fM.
This also shows that when the growth is in the exponential
phase, the growth is increasing slowly and the absorbance at
OD600 is low. This also agrees with the simulation results,
as when the concentration is low, the amplitude of the output
is low. The growth curve remains in the exponential phase.
When the concentration is decreased further, the absorbance
at OD600 will also decrease to reach the same value as in
the lag phase as shown in table V.
(a) high concentration
(b) low concentration
Fig. 9: Bacterial growth curve when the concentration of
vitamin B12 are high and low
TABLE V: Simulation results for absorbance at OD600 with
low vitamin B12 concentration.
Concentration of vitamin B12 Simulation results
10 pM 0.2
5 pM 0.16
1 pM 0.11
V. CONCLUSIONS
In this paper, the effect of the vitamin B12 riboswitch
has been tested at both the cellular and population level.
For the cellular level, the concentration of btub mRNA, the
concentration of the BtuB and the concentration of vitamin
B12 have been studied to determine how they affect the
cells during transcription and translation. The dynamics of
the vitamin B12 riboswitch have been incorporated in a
model with E. coli bacterial growth. At the population level,
the effect of varying the concentration of vitamin B12 has
been tested on the bacterial growth curves of E. coli. The
same analysis has been performed with different bacterial
strains. The effect of changing the concentration of vitamin
B12 in bacterium S. enterica has been tested. The results at
both the cellular and population level have been linked and
the simulation results obtained replicated the experimental
results. The effect of enzyme inhibitors which are vitamin
B12 analogues will be considered in future work. The long
term objective of the study is to provide modelling and
simulation tools to assist in the study of the impact of the
vitamin B12 on health.
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